Cargando…

Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2

PURPOSE: Neoadjuvant chemotherapy (NAC) plays a pivotal role in the treatment of locally advanced breast cancer (LABC); however, breast cancer is a heterogeneous disease, individual responses to chemotherapy are highly variable. Therefore, the purpose of the current research is to identify biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiao-Xiao, Ye, Fu-Gui, Zhang, Jie, Li, Jun-Jing, Chen, Qing-Xia, Lin, Pei-Yang, Song, Chuan-Gui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188109/ https://www.ncbi.nlm.nih.gov/pubmed/30349372 http://dx.doi.org/10.2147/CMAR.S172205

Ejemplares similares

MicroRNA-4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells
por: Zhang, Tao, et al.
Publicado: (2017)

MicroRNA-4530 suppresses cell proliferation and induces apoptosis by targeting RASA1 in human umbilical vein endothelial cells
por: Jing, Li, et al.
Publicado: (2019)

4530 Elucidating the Influence of Chemotherapy (melphalan) and /or C. difficile toxin B Exposure on Beta-catenin Protein Expression in Caco-2 Monolayers
por: Canales, Jailene, et al.
Publicado: (2020)

miR-638 Serves as a Biomarker of 5-Fluorouracil Sensitivity to Neoadjuvant Chemotherapy in Breast Cancer
por: Wang, Bin, et al.
Publicado: (2022)

miR-301a promotes lung tumorigenesis by suppressing Runx3
por: Li, Xun, et al.
Publicado: (2019)

Serum miR-191 and miR-425 as Diagnostic and Prognostic Markers of Advanced Gastric Cancer Can Predict the Sensitivity of FOLFOX Chemotherapy Regimen
por: Bie, Liang-Yu, et al.
Publicado: (2020)

Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel
por: Li, Qian, et al.
Publicado: (2014)

Metabolic Profiling of Bladder Cancer Patients’ Serum Reveals Their Sensitivity to Neoadjuvant Chemotherapy
por: Zhuang, Juntao, et al.
Publicado: (2022)

Correction: Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel
por: Li, Qian, et al.
Publicado: (2015)

MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2
por: Xie, Yuanlong, et al.
Publicado: (2017)

MiR-23a targets RUNX2 and suppresses ginsenoside Rg1-induced angiogenesis in endothelial cells
por: Wu, Xiao-Dong, et al.
Publicado: (2017)

Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2014)

miR-144 Potentially Suppresses Proliferation and Migration of Ovarian Cancer Cells by Targeting RUNX1
por: Han, Shichao, et al.
Publicado: (2018)

CircRUNX2 through has‐miR‐203 regulates RUNX2 to prevent osteoporosis
por: Yin, Qudong, et al.
Publicado: (2018)

Erratum to: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2014)

Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2022)

Retracted: miR-144 Potentially Suppresses Proliferation and Migration of Ovarian Cancer Cells by Targeting RUNX1
por: Han, Shichao, et al.
Publicado: (2018)

miR-338-3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2
por: Wen, Chunyan, et al.
Publicado: (2021)

MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO
por: Kohrs, Nicole, et al.
Publicado: (2016)

miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy
por: Tang, Huan, et al.
Publicado: (2019)

miR-184 delays cell proliferation, migration and invasion in prostate cancer by directly suppressing DLX1
por: Tan, Gui-Geng, et al.
Publicado: (2021)

MicroRNA-125a-3p, -4530, and -92a as a Potential Circulating MicroRNA Panel for Noninvasive Pancreatic Cancer Diagnosis
por: Seyed Salehi, Ali, et al.
Publicado: (2022)

miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA
por: Xia, Yu-Fang, et al.
Publicado: (2017)

miR-539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2
por: Ye, Zhi-Hua, et al.
Publicado: (2018)

lncRNA HAND2‐AS1 overexpression inhibits cancer cell proliferation in hepatocellular carcinoma by downregulating RUNX2 expression
por: Jing, Gui‐Ying, et al.
Publicado: (2021)

Runx2/miR-3960/miR-2861 Positive Feedback Loop Is Responsible for Osteogenic Transdifferentiation of Vascular Smooth Muscle Cells
por: Xia, Zhu-Ying, et al.
Publicado: (2015)

RUNX3 is down‐regulated in glioma by Myc‐regulated miR‐4295
por: Li, Xinxing, et al.
Publicado: (2016)

miR-203 inhibits the traumatic heterotopic ossification by targeting Runx2
por: Tu, Bing, et al.
Publicado: (2016)

LncRNA RUNX1-IT1 is Downregulated in Endometrial Cancer and Binds to miR-21 Precursor to Suppress Its Maturation
por: Liang, Minglin, et al.
Publicado: (2020)

Circular RNA circREPS2 Acts as a Sponge of miR-558 to Suppress Gastric Cancer Progression by Regulating RUNX3/β-catenin Signaling
por: Guo, Xiong, et al.
Publicado: (2020)

MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs
por: Yang, Renjie, et al.
Publicado: (2022)

The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer
por: Sun, Juan, et al.
Publicado: (2021)

The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy
por: Fu, Wen-Fen, et al.
Publicado: (2020)

ZNF521 which is downregulated by miR-802 suppresses malignant progression of Hepatocellular Carcinoma through regulating Runx2 expression
por: Yang, Nan, et al.
Publicado: (2020)

Curcumin suppresses lung cancer progression via circRUNX1 mediated miR‐760/RAB3D axis
por: Wu, Xiaodan, et al.
Publicado: (2022)

MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum
por: Yang, Renjie, et al.
Publicado: (2022)

HCV-Associated Exosomes Upregulate RUNXOR and RUNX1 Expressions to Promote MDSC Expansion and Suppressive Functions through STAT3–miR124 Axis
por: Thakuri, Bal Krishna Chand, et al.
Publicado: (2020)

miR-215 promotes malignant progression of gastric cancer by targeting RUNX1
por: Li, Na, et al.
Publicado: (2015)

CircCDR1as Suppresses Bone Microvascular Endothelial Cell Activity and Angiogenesis Through Targeting miR‐135b/ FIH‐1 Axis
por: Mao, Zheng, et al.
Publicado: (2021)

Expression of miR-129-5p and miR-433 in the serum of breast cancer patients and their relationship with clinicopathological features
por: Xue, Jinhui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tjj5aael08a4had1h9k892fnnr